Your browser doesn't support javascript.
loading
A U.S. Government-Coordinated Effort to Leverage Non-Human Primate Data to Facilitate Ebolavirus Vaccine Development.
Taylor, Kimberly L; Lanning, Lynda; Wolfraim, Lawrence; Shrivastava Gales, Sonia; Sico, Colleen; Dowling, William E; Ward, Lucy A; Florence, William C; Nuzum, Edwin; Bryant, Paula R.
Afiliação
  • Taylor KL; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Lanning L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Wolfraim L; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Shrivastava Gales S; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Sico C; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Dowling WE; Coalition for Epidemic Preparedness Innovations, Washington, DC 20006, USA.
  • Ward LA; U.S. Department of Defense (DOD), Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical (JPM CBRN Medical), Fort Detrick, MD 21702, USA.
  • Florence WC; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Nuzum E; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Bryant PR; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Vaccines (Basel) ; 10(8)2022 Jul 28.
Article em En | MEDLINE | ID: mdl-36016089

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos